[AMRX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
08-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -129.16%
YoY- 52.79%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 559,355 497,633 536,896 528,593 535,075 493,105 510,034 6.36%
PBT -232,731 -9,921 -16,319 -2,043 34,824 14,904 -5,477 1126.09%
Tax 7,350 -3,461 4,140 4,049 2,648 359 1,485 191.28%
NP -120,808 -6,460 -6,377 -4,237 14,532 6,706 -3,037 1073.17%
Tax Rate - - - - -7.60% -2.41% - -
Total Cost 680,163 504,093 543,273 532,830 520,543 486,399 513,071 20.73%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -21.60 -1.30 -1.19 -0.80 2.72 1.36 -0.60 997.45%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.80 -0.04 -0.04 -0.03 0.10 0.05 -0.02 1077.53%
EPS Diluted -0.80 -0.04 -0.04 -0.03 0.10 0.04 -0.02 1077.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.